Urological cancer, Malmö
111 – 120 of 503
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Systematic Review of the Role of BCG in the Treatment of Urothelial Carcinoma of the Prostatic Urethra
(
- Contribution to journal › Scientific review
-
Mark
Re: Short-term Ciprofloxacin Prophylaxis for Prostate Biopsy and Risk of Aortic Aneurysm. Nationwide, Population-based Cohort Study
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Mechanisms of Resistance to Prostate-Specific Membrane Antigen-Targeted Radioligand Therapy in a Mouse Model of Prostate Cancer
2021) In Journal of nuclear medicine : official publication, Society of Nuclear Medicine 62(7). p.989-995(
- Contribution to journal › Article
-
Mark
Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer : Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study
2021) In Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39(20). p.2294-2303(
- Contribution to journal › Article
-
Mark
Study of the relationship between sigma receptor expression levels and some common sigma ligand activity in cancer using human cancer cell lines of the nci-60 cell line panel
(
- Contribution to journal › Article
-
Mark
Apalutamide plus Androgen Deprivation Therapy for Metastatic Castration-Sensitive Prostate Cancer : Analysis of Pain and Fatigue in the Phase 3 TITAN Study
(
- Contribution to journal › Article
-
Mark
Functional and Oncological Outcomes After Open Versus Robot-assisted Laparoscopic Radical Prostatectomy for Localised Prostate Cancer : 8-Year Follow-up
(
- Contribution to journal › Article
-
Mark
Practical considerations for optimising homologous recombination repair mutation testing in patients with metastatic prostate cancer
(
- Contribution to journal › Scientific review
-
Mark
Individual Patient Data Meta-analysis of Discrimination of the Four Kallikrein Panel Associated With the Inclusion of Prostate Volume
(
- Contribution to journal › Article
-
Mark
Updated European Association of Urology Guidelines on Renal Cell Carcinoma : Nivolumab plus Cabozantinib Joins Immune Checkpoint Inhibition Combination Therapies for Treatment-naïve Metastatic Clear-Cell Renal Cell Carcinoma
(
- Contribution to journal › Article